Medical Journals

Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity During Orthostasis in Humans.

Authors:
  • Zhang Rong
  • Levine Benjamin D

From: Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, TX 75231, USA. rongzhang@TexasHealth.org

Stroke; a journal of cerebral circulation

  • Publish Date: Apr 2007
  • ISSN: 1524-4628
  • Volume: 38
  • Issue: 4
  • Pages: 1238-44
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Zhang Rong, Levine Benjamin D, et al. Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity During Orthostasis in Humans.. Stroke Apr 2007;38:1238-44

Abstract

BACKGROUND AND PURPOSE: The underlying mechanisms for reductions in cerebral blood flow (CBF) during orthostasis are not completely understood. This study tested the hypothesis that sympathetic activation causes cerebral vasoconstriction leading to reductions in CBF during lower body negative pressure (LBNP). METHODS: CBF velocity, arterial pressure, and end-tidal CO(2) were measured during LBNP (-30 to -50 mm Hg) in 11 healthy subjects before and after autonomic ganglionic blockade with trimethaphan. Arterial partial pressure of CO(2) also was measured in a subgroup of 5 subjects. Mean arterial pressure during LBNP after blockade was maintained by infusion of phenylephrine. RESULTS: Before blockade, mean arterial pressure did not change during LBNP. However, CBF velocity was reduced in all subjects by 14% (P<0.05). Systolic and pulsatile (systolic-diastolic) CBF velocity were reduced by 18% and 28%, respectively, associated with significant reductions in pulse arterial pressure and end-tidal CO(2) (all P<0.05). After blockade, mean arterial pressure during LBNP was well-maintained and even increased slightly with infusion of phenylephrine. However, reductions in mean, systolic, and pulsatile CBF velocity, pulse arterial pressure, and ETCO(2) were similar to those before blockade. In contrast to reductions in end-tidal CO(2), arterial partial pressure of CO(2) did not change during LBNP. CONCLUSIONS: These data, contrary to our hypothesis, demonstrate that sympathetic vasoconstriction is not the primary mechanism underlying reductions in CBF during moderate LBNP. We speculate that diminished pulse arterial pressure or pulsatile blood flow may reduce cerebral vessel wall shear stress and contribute to reductions in CBF during orthostasis through flow mediated regulatory mechanisms.

Mesh Headings (Keywords): Adult, Autonomic Nerve Block, Baroreflex, Blood Flow Velocity, Blood Pressure, Cerebral Arteries, Cerebrovascular Circulation, Female, Ganglia, Sympathetic, Ganglionic Blockers, Humans, Lower Body Negative Pressure, Male, Phenylephrine, Posture, Stress, Mechanical, Sympathetic Fibers, Postganglionic, Tidal Volume, Trimethaphan, Vasoconstriction, Vasoconstrictor Agents


Check for Full Text / PubMed Unique Identifier (PMID): 17332450


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.